Company intelligence / Profile preview

Onset Therapeutics

Cumberland, Rhode Island, United Statesir.collegiumpharma.com ↗

Ownership: Private
Employees: ~35
Development stage: NDA

Overview

Onset Therapeutics developed and commercialized a portfolio of prescription topical dermatology products using its proprietary Delevo® Foam Technology. The company launched several products for skin and wound care before being spun out from Collegium Pharmaceutical and integrated into PreCision Dermatology in late 2010. It subsequently changed its name to Onset Dermatologics in early 2011. Its assets included a GMP manufacturing facility, an established sales force, and a pipeline of innovative dermatological therapies[2][5][7].

No recent clinical results are available as the brand has been absorbed into successor entities.

Therapeutic areas: Dermatology
Modalities: Topical therapies (including foam-based formulations)Small molecules (delivered topically)
Industry: Biotech

Drug pipeline

5 assets

XTAMPZA

NDA

Indications: Chronic pain, Pain management

4 more assets in the full pipeline.

Request access →

Partnerships

Oculus Innovative Sciences – partnership to co-develop/market Microcyn-based dermatology products targeting atopic dermatitis and related conditions[6].

Beyond the preview

Go deeper on Onset Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onset Therapeutics.

Explore the full profile